Endocrine evaluation of erectile dysfunction
- 6 April 2014
- journal article
- review article
- Published by Springer Nature in Endocrine
- Vol. 46 (3) , 423-430
Abstract
Erectile dysfunction is highly prevalent, affecting up to half of men in their 50–70s, and has been variably associated to a variety of causes including unhealthy lifestyles, such as smoking or overweight, or comorbidities such as hypertension, diabetes mellitus, and neurological disorders. General interest toward ED has exploded since the introduction of phosphodiesterase type 5 inhibitors—oral drugs that are widely accepted as the first line treatment in patients suffering from this conditions. In the last decade, the time lapse between first symptoms of sexual disorders and seeking of medical advice has greatly reduced. Unfortunately, none of the PDE5i has been proven curative, but rather acts as a symptomatic treatment. The availability of very active and safe drugs, however, diminished the space for diagnosis and search of etiological treatments. This is particularly true for the several endocrinopathies associated with ED. A number of epidemiological data support an inverse relationship between sexual health and testosterone levels, and it is well accepted that testosterone deficiency is a good marker of sexual and physical frailty. However, several other hormones, including LH, prolactin, TSH, and FT4 are involved in sexual functioning and should be investigated in a proper work-out of ED. Existing guidelines provide information almost entirely focusing on late-onset hypogonadism and therapeutic strategies; this mini-review aims to provide a wider spectrum of the diagnostic endocrine work-out of ED patients unrevealing the complexity of conditions, overt or subclinical, which can affect ED.Keywords
This publication has 88 references indexed in Scilit:
- Associations of Fatty Liver Disease and Other Factors Affecting Serum SHBG Concentrations: A Population Based Study on 1657 SubjectsHormone and Metabolic Research, 2013
- Impact of the association between elevated oestradiol and low testosterone levels on erectile dysfunction severityAsian Journal of Andrology, 2013
- Testosterone Deficiency in Men: Systematic Review and Standard Operating Procedures for Diagnosis and TreatmentThe Journal of Sexual Medicine, 2013
- Adult Growth Hormone Deficiency – Benefits, Side Effects, and Risks of Growth Hormone ReplacementFrontiers in Endocrinology, 2013
- SOP: Physical Examination and Laboratory Testing for Men with Erectile DysfunctionThe Journal of Sexual Medicine, 2013
- Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2010
- Do androgens play a beneficial role in the regulation of vascular tone? Nongenomic vascular effects of testosterone metabolitesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- The relationship of serum and salivary cortisol levels to male sexual dysfunction as measured by the International Index of Erectile FunctionInternational Journal Of Impotence Research, 2009
- Investigation, treatment and monitoring of late-onset hypogonadism in malesEuropean Journal of Endocrinology, 2008
- ANDROTEST©: A Structured Interview for the Screening of Hypogonadism in Patients with Sexual DysfunctionThe Journal of Sexual Medicine, 2006